A Type 2 diabetes medication called lixisenatide appeared to slow the progression of Parkinson’s disease symptoms in a small, mid-stage trial funded by the French Ministry of Health.
Diabetes medication appears to slow progress of Parkinson’s disease in French-backed trial
